Cancer

125 studies in Cancer

  1. Open-label Study to Assess the Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia
    1. Arizona,
    2. Florida,
    3. Minnesota
  2. Phase I/IIA: Dignity Therapy/Life Plan in Patients With Pancreatic Cancer
    1. Minnesota
  3. MC1351: PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)
    1. Arizona,
    2. Florida,
    3. Minnesota
  4. A Phase II Open-Label, Single-arm, Two-Stage, Multicenter Trial of Pracinostat in Combination With Azacitidine in Elderly (Age 65 Years or Older) Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
    1. Minnesota
  5. S1304, A Phase II Randomized Study Comparing Two Doses of Carfilzomib (NSC-756640) With Dexamethasone for Multiple Myeloma Patients With Relapsed or Refractory Disease
    1. Florida
  6. A Post Approval Registry: ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
    1. Minnesota
  7. A Phase 2, Open-label, Randomized Study to Evaluate the Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
    1. Arizona
  8. Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett s Esophagus Compared With Standard Endoscopy
    1. Minnesota
  9. Phase 1 Dose Finding Study of Belinostat Plus Cyclophosphamide/Vincristine/Doxorubicin/Prednisone (CHOP) Regimen (BelCHOP) for Treatment of Patients With Peripheral T-cell Lymphoma(PTCL)
    1. Minnesota
  10. Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
    1. Minnesota
  1. Prev
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. Next
Jan. 02, 2014

You Are ... The Campaign for Mayo Clinic

Mayo Clinic is a not-for-profit organization. Make a difference today.